Company Overview and News

1
Acquisitive Indian billionaire says he's hungry for deals

2018-09-19 theedgemarkets
(Sept 19): Kumar Mangalam Birla, the billionaire chairman of the acquisitive Indian conglomerate that bears his name, said he’s hungry for more deals after creating the nation’s biggest mobile-phone operator.
HINDALCO VOD VOD 532538 UCLQF ICLQY ALSD 532822 ULTRACEMCO HNDNF VODPF UCLQY IDEA 500440

 
Kumar Mangalam Birla scouts for acquisition targets in US, Europe and India

2018-09-19 moneycontrol
Kumar Mangalam Birla, Chairman of the Aditya Birla Group, said at an event he is looking at acquisition targets in the US, Europe and India that will add value to the company.
HNDNF HINDALCO UCLQY IDEA UCLQF ICLQY 532538 ALSD 532822 500440 ULTRACEMCO

1
Kumar Mangalam Birla says he is hungry for more deals

2018-09-19 livemint
Mumbai: Kumar Mangalam Birla, the billionaire chairman of the acquisitive Indian conglomerate that bears his name, said he’s hungry for more deals after creating the nation’s biggest mobile-phone operator. His Aditya Birla Group continues to look for targets in the US, Europe and India that make business sense and are likely to add value, the 51-year-old said at Bloomberg’s India Economic Forum on 18 September in Mumbai.
HINDALCO VOD VOD 532538 UCLQF ICLQY ALSD 532822 ULTRACEMCO HNDNF VODPF UCLQY IDEA 500440

 
Idea Cellular Limited - Amalgamation/Merger

2018-09-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
IDEA ICLQY 532822

 
Idea Cellular Limited - Change in Director(s)

2018-09-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
IDEA ICLQY 532822

 
TRAI to reduce regulation for WhatsApp, Skype as data consumption on apps rise

2018-09-14 moneycontrol
The Telecom Regulatory Authority of India (TRAI) has decided to reduce regulatory framework for over-the-top (OTT) communication platforms such as WhatsApp and Skype as they drive data consumption on networks, reported Mint.
IDEA ICLQY 532822

 
Trai decides to reduce scope of regulation for WhatsApp, Skype

2018-09-13 livemint
New Delhi: The Telecom Regulatory Authority of India (Trai) has decided to reduce the scope of consultation for the proposed regulatory framework for over-the-top (OTT) communication platforms such as WhatsApp and Skype.
IDEA ICLQY 532822

 
Reliance Jio tops 4G download speed chart; Idea leads in upload speed in August

2018-09-13 moneycontrol
Reliance Jio emerged as the fastest 4G operator with an average peak download speed of 22.3 Mbps on its network in August while Idea Cellular registered the highest upload speed in the month, according to a Trai report.
532454 IDEA ICLQY 532822 BHRQY BHARTIARTL

 
Idea Cellular Limited - Name Change

2018-09-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
IDEA ICLQY 532822

 
Idea Cellular Limited - News Clarification

2018-09-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
IDEA ICLQY 532822

 
Idea Cellular Limited - Credit Rating

2018-09-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
IDEA ICLQY 532822

 
Telecom stocks plan as Jio offers discount on top plan

2018-09-12 thehindubusinessline
Telecom stocks dropped as Jio has offered a discount on top plan. Vodafone Idea Ltd and Bharti Airtel Ltd fell 2.9 per cent and 1.8 per cent, respectively. Billionaire Mukesh Ambani's Reliance Jio Infocomm has offered Rs 100 discount on its top-selling Rs 399 plan.
532454 IDEA ICLQY 532822 BHRQY BHARTIARTL

1
Idea Cellular jumps 3% as Deutsche Bank maintains buy with target Rs 100

2018-09-12 moneycontrol
Shares of Idea Cellular added 3 percent intraday Wednesday as research firm Deutsche Bank maintained buy on company with potential upside of 116.5 percent.
DB VOD VOD VODPF IDEA ICLQY 532822

 
Bharti Airtel down nearly 2% on demand notice towards penalties worth Rs 11 lakh

2018-09-12 moneycontrol
Shares of Bharti Airtel was down nearly 2 percent intraday Wednesday as company received demand notice towards penalties for March quarter.
532454 500325 RELIANCE RIGD IDEA ICLQY 532822 BHRQY BHARTIARTL RLNIY

 
Received demand notices towards penalties for March quarter: Bharti Airtel

2018-09-11 moneycontrol
Telecom operator Bharti Airtel confirmed that it has received demand notices towards penalties totalling Rs 11 lakh for six circles for the quarter ended March 2018.
532454 IDEA ICLQY 532822 BHRQY BHARTIARTL

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...